Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ELANE | P08246 | 4/20 | 0.38 |
| ▸ | CES2 | O00748 | 3/20 | 0.37 |
| ▸ | LTB4R | Q15722 | 5/20 | 0.36 |
| ▸ | LTB4R2 | Q9NPC1 | 5/20 | 0.36 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.35 |
| ▸ | EP300 | Q09472 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7686512 | 1.00 | MEN1 (0.41) | MEN1KMT2AELANECES2LTB4R | |
| SCHEMBL7681914 | 0.84 | ELANE (0.43) | MEN1KMT2AELANECES2ABCB1 | |
| SCHEMBL7681912 | 0.84 | ELANE (0.43) | MEN1KMT2AELANECES2ABCB1 | |
| SCHEMBL7688537 | 0.82 | CES2 (0.36) | MEN1KMT2AELANECES2EP300 | |
| SCHEMBL7688535 | 0.82 | CES2 (0.36) | MEN1KMT2AELANECES2EP300 | |
| SCHEMBL30259580 | 0.82 | CES2 (0.36) | MEN1KMT2AELANECES2EP300 | |
| SCHEMBL7686173 | 0.81 | ELANE (0.46) | MEN1KMT2AELANECES2EP300 | |
| SCHEMBL7686176 | 0.81 | ELANE (0.46) | MEN1KMT2AELANECES2EP300 | |
| SCHEMBL10345487 | 0.75 | PPARG (0.39) | ELANECES2LTB4RLTB4R2 | |
| SCHEMBL7387880 | 0.72 | TSHR (0.39) | MEN1KMT2AABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1021405-B1 | AZETIDINONE DERIVATIVES FOR THE TREATMENT OF HCMV INFECTIONS | BOEHRINGER INGELHEIM CA LTD (CA) | 2002-09-25 | — | — | EP | disclosed |
| US-6242439-B1 | Azetidinone derivatives for the treatment of HCMV infections | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2001-06-05 | — | — | US | disclosed |